Abiopharma

🔍 Warner Gerard H III (Executive)

Company: COOPER COMPANIES, INC. (COO)

Report Date: 2025-12-09

Detailed Transactions and Holdings:

• Acquired 7,960 shares of Performance Stock Units (Derivative)
  Date: 2025-12-09 | Code: A | equity_swap_involved: false | shares_owned_after: 7,960.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 15,921 shares of Restricted Stock Units (Derivative)
  Date: 2025-12-09 | Code: A | equity_swap_involved: false | shares_owned_after: 15,921.00 | transaction_form_type: 4 | Footnotes: F3, F4

Footnotes:

• F1: The Performance Stock Units (PSUs) will vest based on The Cooper Companies, Inc. Total Shareholder Return (TSR) performance relative to the index over a three-year performance period ending October 31, 2028. Between 0% and 200% of the target number of PSUs may vest depending on performance. No shares will vest if minimum TSR performance is not achieved.
• F2: PSUs have no expiration date; they settle after certification of performance results following the performance period.
• F3: 25%/year over 4 years - Jan 8 vest date beginning on Jan 8, 2026.
• F4: This award has no expiration date. Restricted Stock Units will either vest or be forfeited.